Rockefeller Capital Management L.P. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2022$1
-99.9%
280.0%0.00%
Q3 2022$1,000
-50.0%
28
-48.1%
0.00%
Q2 2022$2,000
-50.0%
54
-18.2%
0.00%
Q1 2022$4,000
-84.0%
66
-72.2%
0.00%
Q4 2021$25,000
-51.0%
237
-52.9%
0.00%
Q3 2021$51,000
+5000.0%
503
+3253.3%
0.00%
Q2 2021$1,000
-98.3%
15
-98.1%
0.00%
-100.0%
Q3 2019$58,000
-22.7%
786
-1.5%
0.00%0.0%
Q2 2019$75,000
+7400.0%
798
+4594.1%
0.00%
Q1 2019$1,000170.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders